Page last updated: 2024-09-04

beta-lactams and Blood Poisoning

beta-lactams has been researched along with Blood Poisoning in 130 studies

Research

Studies (130)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (8.46)	18.7374
1990's	3 (2.31)	18.2507
2000's	15 (11.54)	29.6817
2010's	65 (50.00)	24.3611
2020's	36 (27.69)	2.80

Authors

Authors	Studies
Cutrell, JB; Sanders, JM	1
Besch, G; Capellier, G; Chaignat, C; Clairet, AL; Despres, C; Floury, SP; Labro, G; Lagoutte-Renosi, J; Montange, D; Piton, G; Puyraveau, M; Vettoretti, L; Vivet, B; Winiszewski, H	1
Calò, F; Cirillo, P; Coppola, N; Di Caprio, G; Macera, M; Onorato, L	1
Lizza, BD; Micek, ST; Raush, N	1
Chinea, A; Chumbita, M; Cuesta, MA; Español Morales, I; Fernández Abellán, P; Garcia-Vidal, C; González-Sierra, P; Gudiol, C; Guerreiro, M; Lopera, C; Monzó, P; Puerta-Alcalde, P; Rojas, R; Sánchez Pina, JM; Sánchez Vadillo, I; Varela, R; Vázquez, L; Yáñez, L	1
Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH	1
Du, J; Mao, Y; Pang, M; Wang, H; Wu, D; Xu, N; Yan, M; Zhang, X	1
Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M	1
Alexander, KM; Alshaer, MH; Felton, TW; Manigaba, K; Maranchick, N; Mathew, SK; Peloquin, CA; Shoulders, BR	1
Dalton, B; Zeggil, T	1
Klompas, M; Rhee, C; Shappell, CN	1
Atkinson, A; Damulira, C; Fraser, VJ; Guillamet, MCV; Kollef, MH; Micek, S	1
Bavaro, DF; Belati, A; Brindicci, G; Dalfino, L; De Gennaro, N; Dell'Aera, M; Denicolò, S; Di Gennaro, F; Diella, L; Frallonardo, L; Grasso, S; Guido, G; Mosca, A; Papagni, R; Pellegrino, C; Pomarico, F; Ronga, L; Saracino, A; Stufano, M	1
Csomós, Á; Erőss, A; Farkas, R; Galgóczi, J; Holub, L; Karvaly, G; Lakatos, B; Rádler, A; Szabó, BG; Tóth, B; Závorszky, L	1
Davis, KA; Fillius, AG; McClain, DL; Nisly, SA	1
Briscoe, S; Lipman, J; McWhinney, B; Nunez-Nunez, M; Rhodes, NJ; Roberts, JA; Scheetz, MH; Taccone, F; Ungerer, J; Villois, P; Wong, G	1
Al-Hasan, MN; Bookstaver, PB; Drennan, C; Gould, AP; Hill, O; Justo, JA; Kohn, J	1
Crass, RL; Roberts, JA; Williams, P	1
Cobian, J; Hall, B; Miller, J; Wilson, K	1
Fish, DN; Huang, V; Miller, MA; Molina, KC; Morrisette, T	1
Guerci, P; Novy, E; Roger, C; Scala-Bertola, J	1
Ammerlaan, HSM; Bonten, MJM; Buiting, AGM; Deelen, JWT; Dorigo-Zetsma, JW; Kluytmans, JAJW; Rottier, WC; Thijsen, SFT; van der Linden, PD; van Werkhoven, CH; Vlaminckx, BJM; Weersink, AJL	1
Cavaco, LM; Hammerum, AM; Hansen, F; Hasman, H; Roer, L	1
Falagas, ME; Rafailidis, PI	1
Bastow, S; Costello, PG; Gajdosik, DA; Gregorowicz, AJ; Pettit, NN; Purakal, J; Ward, MA	1
Fredlund, H; Källman, J; Liljedahl Prytz, K; Magnuson, A; Prag, M; Sundqvist, M	1
Anderson, M; Arensman, K; Beganovic, M; Dela-Pena, J; LaChance, E; Miller, JL; Shields, M	1
Apata, IW; D'Agata, EMC; Hicks, LA; Kabbani, S; Kear, TM; Kliger, AS; Levenson, DJ; Neu, AM; Patel, PR	1
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A	1
Marsot, A	1
Barker, CIS; Bielicki, J; Clements, M; Gastine, S; Hartmann, C; Hsia, Y; Sharland, M; Standing, JF	1
Bartoletti, M; Bussini, L; Gatti, M; Giannella, M; Ianniruberto, S; Malosso, P; Pancaldi, L; Pascale, R; Paul, M; Rebuffi, C; Scudeller, L; Tedeschi, S; Viale, P	1
Feinberg, JB; Gluud, C; Jakobsen, JC; Korang, SK; Maagaard, M; Perner, A	1
Agnello, S; Coe, K; Day, SR; Reed, E; Smith, JM; Wardlow, LC	1
Arlet, G; Blayau, C; Bonnet, F; Fartoukh, M; Fulgencio, JP; Gallah, S; Garnier, M; Hafiani, M; Mainardi, JL; Pham, T; Quesnel, C; Rozencwajg, S; Vimont, S	1
Almirante, B; Campany, D; Fàbrega, A; Fox, ML; González-López, JJ; Larrosa, N; Miguel, L; Mir, A; Piedra-Carrasco, N; Ruiz-Camps, I; Viñado, B	1
Akova, M; Almirante, B; Bonomo, RA; Calbo, E; Carmeli, Y; Daikos, G; Doi, Y; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Harris, PNA; Hernández-Torres, A; Hsueh, PR; Martínez-Martínez, L; Navarro-Francisco, C; Oliver, A; Pascual, Á; Paterson, DL; Peña, C; Pérez, F; Pezzani, MD; Pitout, J; Rodríguez-Baño, J; Ruiz-Garbajosa, P; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Tuon, FF; Venditti, M; Viale, P	1
Bonten, MJM; Cremer, OL; Ong, DSY; Thwaites, GE; van Werkhoven, CH	1
Paul, M; Theuretzbacher, U	1
Falagas, ME; Maliaros, A; Samonis, G; Vardakas, KZ; Voulgaris, GL	1
Chopra, A; Cies, JJ; Enache, A; Moore, WS	1
Heffernan, A; Lipman, J; Roberts, J	1
Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S	2
Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J	1
Zeitlinger, M	1
Akova, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; de la Calle, C; Falcone, M; Farcomeni, A; Gasch, O; Gozalo, M; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández-Torres, A; Hsueh, PR; Karaiskos, I; Lowman, W; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pitout, J; Prim, N; Rodríguez-Baño, J; Rodriguez-Gomez, J; Ruiz-Garbajosa, P; Russo, A; Schwaber, MJ; Souli, M; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, PL	1
Hampton, N; Kollef, MH; Micek, ST; Teshome, BF; Vouri, SM	1
Billot, L; Brett, SJ; Cotta, MO; Davis, JS; De Waele, JJ; Dulhunty, JM; Finfer, S; Glass, P; Knowles, S; Lipman, J; McGuinness, S; Myburgh, J; Paterson, DL; Peake, S; Rajbhandari, D; Rhodes, A; Roberts, JA; Shirwadkar, C; Starr, T; Taylor, C	1
Davis, SL; January, SE; Kenney, RM; Veve, MP; Zervos, MJ; Zoratti, EM	1
Fisher, MA; Spivak, ES; Timbrook, TT; Tritle, BJ	1
Bellomo, R; Davis, JS; Dulhunty, JM; Eastwood, GM; Gomersall, C; Lipman, J; Myburgh, J; Paterson, DL; Roberts, JA; Shirwadkar, C; Webb, SA	2
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ	1
Gupta, N; Rodrigues, C; Shetty, A; Soman, R	1
Bellomo, R; Davis, JS; Dulhunty, JM; Eastwood, GM; Gomersall, C; Lipman, J; Myburgh, J; Paterson, DL; Paul, SK; Roberts, JA; Shirwadkar, C; Starr, T; Udy, AA; Webb, SA	1
Beumier, M; Casu, GS; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Taccone, FS; Vincent, JL; Wolff, F	1
Beumier, M; Casu, GS; Cotton, F; Hites, M; Jacobs, F; Seyler, L; Taccone, FS; Vincent, JL	1
Blackmore, T; Losco, G; Studd, R	1
Carlier, M; De Waele, JJ	1
Chow, KM; Li, PK	1
Adam, R; Michels, G; Müller, C; Nosseir, NS; Pfister, R; Wiesen, MH	1
Beumier, M; Casu, GS; Cotton, F; Hites, M; Jacobs, F; Taccone, FS; Vincent, JL; Wolff, F	1
Avni, T; Leibovici, L; Paul, M; Shiber, S; Yahav, D	1
Kimura, K	1
Antonucci, E; Beumier, M; Cristallini, S; de Backer, D; Donadello, K; Jacobs, F; Roberts, JA; Rondelet, B; Scolletta, S; Taccone, FS; Vincent, JL	1
Bursle, E; Cotta, MO; Gowen, B; Lipman, J; McWhinney, B; Roberts, JA; Truloff, N; Ungerer, JP	1
Eliasson, E; Giske, C; Hanberger, H; Leander, G	1
Berkley, JA; Obiero, CW; Seale, AC	1
Dunning, J; Roberts, J	1
Carlier, M; De Waele, JJ; Lipman, J; Roberts, JA; Stove, V; Verstraete, AG	1
Bellomo, R; Davis, JS; Dulhunty, JM; Eastwood, GM; Gomersall, C; Lipman, J; Myburgh, J; Paterson, DL; Paul, SK; Roberts, JA; Shirwadkar, C; Starr, T; Webb, SA	1
Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V	1
Chastre, J; Luyt, CE	1
Abd Rahman, AN; Abdul-Aziz, MH; Hasan, MS; Jamal, JA; Lipman, J; Mat-Nor, MB; Rai, V; Roberts, JA; Staatz, CE; Sulaiman, H; Wallis, SC; Wong, KK	1
Jeon, YL; Kang, SY; Kim, MH; Lee, MY; Lee, WI	1
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P	1
Abdul-Aziz, MH; Bellomo, R; Cotta, MO; Davis, JS; Dulhunty, JM; Lipman, J; Myburgh, J; Roberts, JA	1
Brienza, N; Bruno, F; Dalfino, L	1
Hagel, S; Pletz, M	1
El-Helali, N; May, F; Misset, B; Timsit, JF	1
Brink, AJ; Kiem, S; Richards, GA; Schentag, J; Schillack, V	1
Deshpande, S; Ellis, R; Horsfield, P	1
Boersma, WG; van der Eerden, MM	1
Cumps, J; Delattre, IK; Dugernier, T; Jacobs, F; Laterre, PF; Musuamba, FT; Spapen, H; Taccone, FS; Verbeeck, RK; Vincent, JL; Wallemacq, PE; Wittebole, X	1
Kamath, S; Mallaya, S; Shenoy, S	1
Del Prado, G; García, E; Huelves, L; Naves, P; Ponte, C; Rodríguez-Cerrato, V; Ruiz, V; Soriano, F	1
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X	1
Dogra, V; Loomba, P; Mishra, B; Taneja, J; Thakur, A	1
Jeurissen, A; Rutsaert, R	1
Abdul-Baki, H; Aoun, E; Chaar, HF; El Hajj, II; Hashash, JG; Kanj, SS; Kyriacos, SB; Mansour, NM; Mroueh, M; Sharara, AI	1
Cao, H; Cen, Y; Jiang, W; Li, B; Li, J; Liu, X; Pan, X; Zheng, J; Zheng, X; Zhou, H	1
Boselli, E; Breilh, D; Fleureau, C; Gordien, JB; Janvier, G; Joanes-Boyau, O; Rapaport, S; Saux, MC; Texier-Maugein, J	1
Corona, A; Singer, M	1
López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C	1
Heizmann, P; Heizmann, WR; Lode, H	1
Fleer, A; Hemels, MA; Krediet, TG; Paauw, A	1
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P	1
Lipman, J; Roberts, JA; Roberts, MS; Sinnollareddy, MG	1
Aschenbrenner, LM; Fahnoe, KC; Finegan, SM; Lacey, BM; Lemmon, MM; McPherson, CJ; Mueller, JP; O'Donnell, JP; Tadakamalla, B; Tomaras, AP	1
Drusano, GL; Lodise, TP	1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F	1
Artigas, A; Díaz-Martín, A; Ferrer, R; Garnacho-Montero, J; Levy, MM; Lopez-Pueyo, MJ; Martín-Loeches, I; Martínez-González, ML; Ortiz-Leyba, C; Piacentini, E	1
Cotton, F; Deprez, G; Gulbis, B; Hites, M; Jacobs, F; Seyler, L; Taccone, F; Vincent, JL; Wolff, F	1
Benuri-Silbiger, I; Leibovici, L; Paul, M; Soares-Weiser, K	1
Michelet, C; Tattevin, P	1
Gordon, A; Jeffery, HE	1
Bodmann, KF	1
Lipman, J; Roberts, JA	1
Alves Filho, JC; Cunha, FQ; D'Avila, LC; da Cunha, AA; de Oliveira, JR; Dias, FS; Leite, CE; Lunardelli, A; Machado, DP; Nunes, FB; Poli de Figueiredo, CE; Poloni, JA; Ruschel, RE; Saciura, VC; Simões Pires, MG	1
Harbarth, S; Nobre, V; Pittet, D	1
Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD	1
Daenas, C; Gourgoulianis, KI; Makris, D; Papaioannou, AI	1
Mazzei, T; Novelli, A	1
Klesel, N; Limbert, M	1
Greene, WH	1
Barre, V; Blanc, T; Devaux, AM; Ensel, P; Nouvellon, M	1
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Yuste, J	1
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Prieto, J; Yuste, J	1
Arlet, G; Fournier, G; Marie, O; Philippon, A; Rouveau, M; Sanson-le Pors, MJ; Schlemmer, B	1
Fauser, AA; Lang, E; Schmid, J	1
Almdahl, SM; Andersen, BM; George, R; Gilfillian, A; Hotvedt, R; Olafsen, K; Sørlie, D	1
Shah, PM	1
Brown, DF; Taylor, CE; Warner, M; Warren, RE	1
DeJace, P; Klastersky, J	1
Brückner, O; Hahn, H; Marre, R; Trautmann, M	1
Bryan, LE; Godfrey, AJ; Schollardt, T	1
Young, LS	1

Reviews

24 review(s) available for beta-lactams and Blood Poisoning

Article	Year
Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis. International journal of antimicrobial agents, 2022, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Treatment Outcome	2022
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 128 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis	2023
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections	2020
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors? Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam	2020
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children? Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2020, Volume: 23 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Models, Biological; Sepsis; Severity of Illness Index; Shock, Septic; Young Adult	2020
Variation in Target Attainment of Beta-Lactam Antibiotic Dosing Between International Pediatric Formularies. Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; beta-Lactams; Child; Child, Preschool; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Pediatrics; Pneumonia; Practice Guidelines as Topic; Sepsis; Socioeconomic Factors	2021
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda. International journal of antimicrobial agents, 2021, Volume: 57, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Blood Culture; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Observational Studies as Topic; Quality Indicators, Health Care; Randomized Controlled Trials as Topic; Sepsis	2021
The effects of adding quinolones to beta-lactam antibiotics for sepsis. Acta anaesthesiologica Scandinavica, 2021, Volume: 65, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Humans; Quality of Life; Quinolones; Sepsis	2021
Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Sepsis; Survival Analysis; Time; Treatment Outcome	2018
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:38 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Guideline Adherence; Humans; Intensive Care Units; Linezolid; Metabolic Clearance Rate; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Shock, Septic; Teicoplanin; Vancomycin	2014
β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1 Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Clostridioides difficile; Diarrhea; Humans; Randomized Controlled Trials as Topic; Sepsis; Survival Analysis; Treatment Outcome	2015
[Series of studies concerning group B streptococci with reduced penicillin susceptibility (PRGBS)]. Nihon saikingaku zasshi. Japanese journal of bacteriology, 2014, Volume: 69, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Infant, Newborn; Meningitis, Bacterial; Penicillin Resistance; Penicillin-Binding Proteins; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Time Factors	2014
[Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit]. Lakartidningen, 2015, Mar-24, Volume: 112 Topics: Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Sepsis	2015
Empiric treatment of neonatal sepsis in developing countries. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Developing Countries; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Sepsis	2015
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials. American journal of respiratory and critical care medicine, 2016, 09-15, Volume: 194, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sepsis	2016
β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review. Clinical and experimental pharmacology & physiology, 2012, Volume: 39, Issue:6 Topics: beta-Lactam Resistance; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Sepsis	2012
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ (Clinical research ed.), 2004, Mar-20, Volume: 328, Issue:7441 Topics: Aminoglycosides; beta-Lactams; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Sepsis; Treatment Outcome	2004
Antibiotic regimens for suspected late onset sepsis in newborn infants. The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3 Topics: Aminoglycosides; Bacterial Infections; beta-Lactams; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Sepsis; Time Factors	2005
Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy, 2005, Volume: 51, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance; Germany; Humans; Intensive Care Units; International Cooperation; Pneumonia; Practice Guidelines as Topic; Sepsis; Severity of Illness Index	2005
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clinical pharmacokinetics, 2006, Volume: 45, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin	2006
Does antibiotic selection impact patient outcome? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-01, Volume: 44, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Pneumococcal; Prognosis; Sepsis; Survival Rate	2007
[Pharmacological rationale for choice of antibiotics for intraabdominal infections]. Le infezioni in medicina, 2008, Volume: 16 Suppl 1 Topics: Abdominal Abscess; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Digestive System Diseases; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Peritonitis; Sepsis; Tigecycline; Treatment Outcome; Virginiamycin	2008
The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts. Bulletin of the New York Academy of Medicine, 1984, Volume: 60, Issue:4 Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Immunosuppression Therapy; Neoplasms; Neutropenia; Sepsis	1984
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986

Trials

10 trial(s) available for beta-lactams and Blood Poisoning

Article	Year
A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2019, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Critical Illness; Drug Administration Schedule; Humans; Infusions, Intravenous; Meropenem; New Zealand; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Treatment Outcome; United Kingdom	2019
A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2013, Volume: 15, Issue:3 Topics: Adult; Aged; beta-Lactams; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome	2013
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. American journal of respiratory and critical care medicine, 2015, 12-01, Volume: 192, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Prospective Studies; Sepsis; Survival Analysis; Treatment Outcome	2015
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive care medicine, 2016, Volume: 42, Issue:10 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Critical Care; Critical Illness; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Sepsis; Statistics, Nonparametric	2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome	2016
Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration. Southern medical journal, 2011, Volume: 104, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ertapenem; Female; Humans; Jaundice, Obstructive; Male; Middle Aged; Sepsis; Young Adult	2011
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin. Clinical biochemistry, 2012, Volume: 45, Issue:10-11 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome	2012
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Sepsis; Treatment Outcome	2013
A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation. British journal of haematology, 1990, Volume: 76 Suppl 2 Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Bone Marrow Transplantation; Drug Evaluation; Drug Therapy, Combination; Female; Glycopeptides; Humans; Male; Sepsis; Teicoplanin	1990
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986

Other Studies

97 other study(ies) available for beta-lactams and Blood Poisoning

Article	Year
"The Early Beta-Lactam Catches the Germ": Empiric Antimicrobial Sequence in Bloodstream Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-24, Volume: 75, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Humans; Lactams; Sepsis; Vancomycin	2022
β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study. Journal of critical care, 2022, Volume: 67 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Meropenem; Piperacillin; Prospective Studies; Sepsis	2022
Antibiotic Optimization in the Intensive Care Unit. Seminars in respiratory and critical care medicine, 2022, Volume: 43, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Intensive Care Units; Retrospective Studies; Sepsis; Vancomycin	2022
Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Febrile Neutropenia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Retrospective Studies; Sepsis; Spain	2022
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Yonsei medical journal, 2022, Volume: 63, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2022
Factors associated with the decision to administer β-lactams via prolonged infusion in patients with sepsis: a prospective observational cohort study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 124 Topics: beta-Lactams; Cohort Studies; Humans; Prospective Studies; Sepsis; Shock, Septic	2022
Beta-lactam target attainment and associated outcomes in patients with bloodstream infections. International journal of antimicrobial agents, 2023, Volume: 61, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Sepsis	2023
β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 06-16, Volume: 76, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Sepsis	2023
Do Prolonged Infusions of β-Lactam Antibiotics Improve Outcomes in Critically Ill Patients With Sepsis? JAMA, 2023, 07-11, Volume: 330, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Infusions, Intravenous; Monobactams; Sepsis; Time Factors; Treatment Outcome	2023
Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock. International journal of antimicrobial agents, 2023, Volume: 62, Issue:4 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Sepsis; Shock, Septic	2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study. The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Propensity Score; Retrospective Studies; Sepsis	2023
[Therapeutic drug monitoring of beta-lactam antibiotics in critically ill adult patients]. Orvosi hetilap, 2023, 12-03, Volume: 164, Issue:48 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Drug Monitoring; Humans; Monobactams; Sepsis	2023
Oral antibiotics for the treatment of Gram-negative bloodstream infections: A retrospective comparison of three antibiotic classes. Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Administration, Intravenous; Administration, Oral; Aged; Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Inpatients; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination	2020
β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. The Journal of antimicrobial chemotherapy, 2020, 02-01, Volume: 75, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sepsis	2020
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors; Sepsis	2020
The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically ill. Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Sepsis	2020
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department. The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin	2020
Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection. Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Betacoronavirus; Cefepime; Coinfection; Confusion; Coronavirus Infections; COVID-19; Critical Illness; Cross Infection; Deep Sedation; Delirium; Drug Monitoring; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pandemics; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Sepsis	2020
Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:2 Topics: Aged; Aged, 80 and over; Aminoglycosides; beta-Lactams; Combined Modality Therapy; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Netherlands; Prospective Studies; Sepsis; Survival Analysis; Treatment Outcome	2021
Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Recurrence; Sepsis; Virulence; Virulence Factors	2020
Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives. Expert review of anti-infective therapy, 2020, Volume: 18, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Sepsis; Treatment Outcome	2020
Effect of IV Push Antibiotic Administration on Antibiotic Therapy Delays in Sepsis. Critical care medicine, 2020, Volume: 48, Issue:8 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Sepsis; Time Factors	2020
Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. PloS one, 2020, Volume: 15, Issue:7 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Gentamicins; Hospitalization; Humans; Male; Organ Dysfunction Scores; Retrospective Studies; Sepsis	2020
Fluoroquinolone versus Beta-Lactam Oral Step-Down Therapy for Uncomplicated Streptococcal Bloodstream Infections. Antimicrobial agents and chemotherapy, 2020, 10-20, Volume: 64, Issue:11 Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Fluoroquinolones; Humans; Retrospective Studies; Sepsis; Streptococcus	2020
Opportunities to Improve Antibiotic Prescribing in Outpatient Hemodialysis Facilities: A Report From the American Society of Nephrology and Centers for Disease Control and Prevention Antibiotic Stewardship White Paper Writing Group. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021, Volume: 77, Issue:5 Topics: Ambulatory Care; Ambulatory Care Facilities; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Blood Culture; Centers for Disease Control and Prevention, U.S.; Clinical Audit; Decision Support Systems, Clinical; Formative Feedback; Humans; Infection Control; Interdisciplinary Communication; Kidney Failure, Chronic; Nephrology; Patient Transfer; Quality Improvement; Renal Dialysis; Sepsis; Societies, Medical; Staphylococcal Infections; Staphylococcus aureus; United States	2021
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections. International journal of antimicrobial agents, 2021, Volume: 58, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2021
Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study. Critical care (London, England), 2017, Jun-28, Volume: 21, Issue:1 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Sepsis	2017
Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Lactams; Drug Combinations; Ertapenem; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Sarcoma, Myeloid; Sepsis; Thienamycins; Transplantation, Homologous; Treatment Outcome	2018
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. International journal of antimicrobial agents, 2017, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Global Health; Humans; Male; Middle Aged; Retrospective Studies; Sepsis	2017
Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:2 Topics: Aminoglycosides; beta-Lactams; Critical Illness; Drug Therapy, Combination; Humans; Intensive Care Units; Kidney; Observational Studies as Topic; Randomized Controlled Trials as Topic; Sepsis	2018
β-lactam prolonged infusion: it's time to implement! The Lancet. Infectious diseases, 2018, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Infusions, Intravenous; Sepsis; Time	2018
β-lactam Therapeutic Drug Management in the PICU. Critical care medicine, 2018, Volume: 46, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Medication Therapy Management; Practice Guidelines as Topic; Retrospective Studies; Sepsis	2018
Re: 'Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Sepsis	2018
[Urosepsis]. Der Urologe. Ausg. A, 2018, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins	2018
[Urosepsis]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018, Volume: 113, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
Extended infusion-putting the benefit into context. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Infusions, Intravenous; Sepsis	2018
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. International journal of antimicrobial agents, 2018, Volume: 52, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Decision Support Techniques; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome	2018
Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance. Pharmacotherapy, 2019, Volume: 39, Issue:3 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic; Tertiary Care Centers; Time Factors	2019
Impact of Reported β-Lactam Allergy on Management of Methicillin-Sensitive Journal of pharmacy practice, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Methicillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus	2020
Penicillin as a Potential Agent for Dual β-Lactam Therapy for Enterococcal Endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 03-03, Volume: 70, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Penicillins; Sepsis	2020
Reply to Soman et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Sepsis	2013
Reply to Soman et al and Frippiat et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Are prolonged/continuous infusions of β-lactams for all? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Can changes in renal function predict variations in β-lactam concentrations in septic patients? International journal of antimicrobial agents, 2013, Volume: 42, Issue:5 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Pseudomonas Infections; Sepsis; Serum	2013
β-lactam antibiotic concentrations during continuous renal replacement therapy. Critical care (London, England), 2014, May-22, Volume: 18, Issue:3 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Renal Replacement Therapy; Retrospective Studies; Sepsis	2014
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate. BJU international, 2014, Volume: 113 Suppl 2 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional	2014
Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy? Critical care (London, England), 2014, Jun-26, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Renal Replacement Therapy; Sepsis	2014
Acute kidney injury: Antibiotic therapy during CRRT--getting the dose just right. Nature reviews. Nephrology, 2014, Volume: 10, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Renal Replacement Therapy; Sepsis	2014
Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva anestesiologica, 2015, Volume: 81, Issue:5 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Critical Care; Critical Illness; Disease Progression; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nervous System Diseases; Pseudomonas aeruginosa; Retrospective Studies; Sepsis	2015
β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Sepsis; Serum; Thienamycins; Treatment Outcome	2015
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring. Infectious diseases (London, England), 2015, Volume: 47, Issue:10 Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Female; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Thienamycins	2015
Continuous infusion of beta-lactam antibiotics to treat severe sepsis: a waste of time or worth the hassle? British journal of hospital medicine (London, England : 2005), 2015, Volume: 76, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Sepsis	2015
A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis	2015
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:2 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins	2016
Continuous β-Lactam Infusion to Optimize Antibiotic Use for Severe Sepsis. A Knife Cutting Water? American journal of respiratory and critical care medicine, 2015, Dec-01, Volume: 192, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Sepsis	2015
A Case of Sepsis in a 92-Year-Old Korean Woman Caused by Aerococcus urinae and Identified by Sequencing the 16S Ribosomal RNA Gene. Laboratory medicine, 2016, Volume: 47, Issue:2 Topics: Aerococcus; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Meropenem; Remission Induction; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, RNA; Thienamycins; Urinary Tract Infections	2016
Does the journey toward efficacy and safety of high dose beta-lactams pass through therapeutic drug monitoring? Minerva anestesiologica, 2016, Volume: 82, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Monitoring; Humans; Sepsis	2016
[Continuous infusion of beta-lactam antibiotics in severe sepsis (BLISS)]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2016, Volume: 111, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Infusions, Intravenous; Sepsis	2016
Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis. Critical care (London, England), 2016, 08-01, Volume: 20, Issue:1 Topics: Acute Kidney Injury; beta-Lactams; Humans; Intensive Care Units; Prevalence; Renal Dialysis; Sepsis; Time Factors	2016
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. International journal of antimicrobial agents, 2009, Volume: 33, Issue:5 Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Chromatography, High Pressure Liquid; Cohort Studies; Critical Illness; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Prospective Studies; Sepsis; Time Factors; Urine; Young Adult	2009
Killing with kindness? Drug reaction eosinophilia with systemic symptoms (DRESS) masquerading as acute severe sepsis. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Drug Hypersensitivity; Eosinophilia; Humans; Leukocyte Count; Male; Sepsis	2009
Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia. The European respiratory journal, 2009, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Bronchiolitis; Community-Acquired Infections; Critical Care; Cystic Fibrosis; Humans; Inflammation; Macrolides; Pneumonia; Randomized Controlled Trials as Topic; Sepsis; Treatment Outcome	2009
Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin. Clinical biochemistry, 2010, Volume: 43, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Calibration; Critical Illness; Drug Dosage Calculations; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Empirical Research; Female; Humans; Male; Middle Aged; Models, Theoretical; Sepsis; Young Adult	2010
Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram. Indian journal of pediatrics, 2010, Volume: 77, Issue:1 Topics: Anti-Infective Agents; beta-Lactams; Cohort Studies; Cross Infection; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Prevalence; Risk Factors; Sepsis	2010
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci. International journal of antimicrobial agents, 2010, Volume: 35, Issue:6 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Novobiocin; Peritoneum; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Survival Analysis; Treatment Outcome	2010
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Critical care (London, England), 2010, Volume: 14, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins	2010
Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. Journal of infection in developing countries, 2010, Sep-03, Volume: 4, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tetracycline	2010
β-lactam antibiotics in continuous infusion in critically ill patients. Critical care (London, England), 2010, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Infusions, Intravenous; Sepsis	2010
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacilli International immunopharmacology, 2011, Volume: 11, Issue:8 Topics: Adenosine; Ampicillin; Animals; Anti-Bacterial Agents; Antigens, CD; Artemisinins; Artesunate; Bacterial Load; beta-Lactams; Cytokines; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Interleukin-6; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nod2 Signaling Adaptor Protein; Oxacillin; Penicillin-Binding Proteins; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha	2011
Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion. Minerva anestesiologica, 2011, Volume: 77, Issue:11 Topics: Aged; Anti-Bacterial Agents; Bacteria; beta-Lactams; Critical Illness; Ertapenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis	2011
An epistemological dilemma: is ertapenem adequate to treat severe infections in critically ill patients? Minerva anestesiologica, 2011, Volume: 77, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Sepsis	2011
First detection of blaIMI-2 gene in a clinical Escherichia coli strain. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA	2012
[Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cell Wall; Critical Care; Cross Infection; Drug Therapy, Combination; Exotoxins; Guideline Adherence; Humans; Immunization; Interleukin-8; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors	2012
Reduced expression of PBP-2A by neonatal mecA-positive coagulase-negative staphylococci (CoNS) blood isolates: β-lactams are useful first-line agents for the treatment of neonatal CoNS sepsis, restricting the use of vancomycin. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactams; Coagulase; DNA, Bacterial; Gene Expression; Humans; Infant, Newborn; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sepsis; Staphylococcus; Vancomycin	2012
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Blotting, Western; Cloning, Molecular; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Library; Gram-Negative Bacteria; Mice; Porins; Pseudomonas aeruginosa; Sepsis; Siderophores	2012
Saving lives with optimal antimicrobial chemotherapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Sepsis	2013
Case-control study of drug monitoring of β-lactams in obese critically ill patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult	2013
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Critical care (London, England), 2012, Nov-18, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Spain; Treatment Outcome	2012
Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients. Talanta, 2013, Jan-15, Volume: 103 Topics: Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Intensive Care Units; Sepsis; Spectrophotometry, Ultraviolet; Tissue Distribution	2013
[Septicemia]. La Revue du praticien, 2004, Jun-30, Volume: 54, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Diagnosis, Differential; Drug Therapy, Combination; Female; France; Humans; Male; Middle Aged; Sepsis; Survival Rate	2004
Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Animals; Arginine; Ascitic Fluid; Aztreonam; beta-Lactams; Ceftriaxone; Drug Therapy, Combination; Interleukin-10; Interleukin-1beta; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli. Journal of medical microbiology, 2007, Volume: 56, Issue:Pt 11 Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis	2007
Septic embolism with subacute onset. The Journal of infection, 2008, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Diagnosis, Differential; Humans; Male; Middle Aged; Periodontal Diseases; Pulmonary Embolism; Radiography; Sepsis	2008
[Studies on the effects of a modified immunoglobulin and beta-lactam antibiotics in the experimental mouse septicemia (author's transl)]. Arzneimittel-Forschung, 1981, Volume: 31, Issue:9 Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; gamma-Globulins; Mice; Sepsis; Time Factors	1981
[Neonatal septicemia due to Pneumococcus resistant to beta-lactam antibiotics]. Archives francaises de pediatrie, 1993, Volume: 50, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Sepsis; Streptococcus pneumoniae	1993
Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumococcal Infections; Sepsis	2002
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5 Topics: Amoxicillin; Animals; Antibodies, Bacterial; Antibody Specificity; beta-Lactams; Cefotaxime; Disease Models, Animal; Humans; Immune Sera; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Treatment Outcome	2002
Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Paris; R Factors; Respiratory System; Risk Factors; Sepsis; Surgical Wound Infection; Urinary Tract	1990
Multiply beta-lactam resistant Enterobacter cloacae infections linked to the environmental flora in a unit for cardiothoracic and vascular surgery. Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Departments; Humans; Male; Middle Aged; Operating Rooms; Sepsis; Serotyping; Surgery Department, Hospital; Surgical Wound Infection; Vascular Surgical Procedures	1989
Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Citrobacter; Enzyme Induction; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sepsis	1987
Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Humans; Microbial Sensitivity Tests; Sepsis	1988
Prospective addition of beta-lactamase to blood culture medium. Journal of medical microbiology, 1988, Volume: 26, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Blood; Culture Media; Enzyme Stability; Escherichia coli; Humans; Hydrolysis; Sepsis; Staphylococcus aureus; Streptococcus	1988
Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance. European journal of clinical microbiology, 1987, Volume: 6, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Europe; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Sepsis; Staphylococcal Infections; Staphylococcus	1987
Comparative efficacy of different beta-lactam antibiotics and gentamicin in Klebsiella pneumoniae septicaemia in neutropenic mice. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Neutropenia; Sepsis	1986
Virulence of Pseudomonas aeruginosa strains with mechanisms of microbial persistence for beta-lactam and aminoglycoside antibiotics in a mouse infection model. Canadian journal of microbiology, 1985, Volume: 31, Issue:4 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Iron-Dextran Complex; Lethal Dose 50; Mice; Mutation; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Virulence	1985
Double beta-lactam therapy in the immunocompromised host. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Neutropenia; Sepsis	1985